HLTH MATTERS

Podcast

Thursday, Apr 13, 2023 | 12:00 AM ET

S3 Ep30: Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

For most cancers, Black Americans have the highest death rate and shortest survival of any patient population.


And access to genetic testing is key to eliminating this disparity.


Feyi Olopade Ayodele is Cofounder and CEO of CancerIQ, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention.


Under Feyi’s leadership, CancerIQ has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors.


On this episode of HLTH Matters, Feyi joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit.


Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient.


 Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages.


Topics Covered

  • Disparities in breast cancer outcomes between Black women and other patient populations
  • Why Feyi built CancerIQ to solve for the disparity in access to genetic testing
  • How CancerIQ makes it easy for providers to navigate patients to the right precision cancer prevention program
  • Why Feyi encourages primary genetic care vs. specialty genetic care
  • How CancerIQ helps patients initiate conversations on cancer prevention with their providers
  • How CancerIQ is closing the gap for African American and rural patient populations
  • What CancerIQ does to help patients adhere to a cancer prevention plan
  • How CancerIQ recognizes the emotional journey associated with a cancer diagnosis
  • Feyi’s vision to make CancerIQ part of everyone’s preventative care visit and detect cancer in its earliest stages


 


Connect with Feyi Olopade Ayodele

CancerIQ


 

Connect with Dr. Jessica Shepherd

HLTH

Dr. Shepherd on Twitter

Dr. Shepherd on LinkedIn

 


Resources

NCCN Guidelines

Small Talk Baby Podcast

FEATURING

Feyi Olopade AyodeleCo-Founder & CEO, CancerIQ

You May Also Enjoy

April 4, 2023

S3 Ep27: Connectivity for A Better Healthcare Expe...

Thom Bales, Principal, PricewaterhouseCoopers

Patty Obermaier, VP, Health & Life Sciences, Microsoft

May 4, 2023

S3 Ep36: Providing Food as Medicine for Underserve...

Ashley Tyrner, Founder & CEO, FarmboxRx

March 9, 2023

S3 Ep21: Exploring Root-Cause Resolution Medicine—...

Dr. Robin Berzin, MD, CEO & Founder, Parsley Health

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved